Don't have a Account?
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission
Welcome Guest | Connect with us
Updated on 25 May 2012
Teva, Sanofi, Eisai and Bayer are other big names in the drug industry that resorted to reducing headcount by 500 to 1,000 in 2011.
Source: Global Pharma and Biotech M&A Report-2012, IMAP
Get direct access to more such reports. Subscribe to BioSpectrum Bureau
Your comment has been successfully added, and will be posted shortly. Thank you for your contribution!
Sign in
Notify me of follow-up comments via e-mail address
Post Comment loading...
Ranbaxy controversy: What have been the highlights?...
Will Ranbaxy, Wockhardt incidents affect brand India?...
How well is the industry prepared to fight H7N9 bird...
Have the Chinese created a new destructive flu virus?...
What can India do to streamline its regulatory processes?...
How has India been able to keep Polio at bay?
What's with the medtech registration scenario in Taiwan?...
Editor's Pick
Featured Links
Survey Box
Ranbaxy Controversy
Will the Ranbaxy controversy end the Indian pharma dominion in the US market?
Send this article by email